The development of a significantly improved device, food for special medical purposes, for patients suffering from chronic cough and other undesirable effects resulting from smoking or inhalation of air contaminated by cigarettes. (Q81013): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item)
(‎Removed claim: summary (P836): Reference_reference_programme_aids:SA.42799 (2015/X), aid_de_de minimis:§ 42 of the Regulation of the Minister of Infrastructure and Development of 10 July 2015 on the granting of financial assistance by the Polish Agency for Enterprise Development in the framework of the OP Smart Growth 2014-2020.The project involves the development and testing of a significantly improved device for patients suffering from chronic cough and other undesirable...)
Property / summary
Reference_reference_programme_aids:SA.42799 (2015/X), aid_de_de minimis:§ 42 of the Regulation of the Minister of Infrastructure and Development of 10 July 2015 on the granting of financial assistance by the Polish Agency for Enterprise Development in the framework of the OP Smart Growth 2014-2020.The project involves the development and testing of a significantly improved device for patients suffering from chronic cough and other undesirable effects resulting from smoking or the inhalation of air contaminated by cigarettes, either from the main stream (smoke to be expired by the smoker) or by smoke to smoke the cigarette.The product of the category of FSMP to be used under medical supervision has been designed for patients with a so-called ‘couchery’, a cough that appears after cigarettes or smoking in other tobacco products and can lead to the throat.Side effects of active and passive smoking include almost every body of the organism, but have a negative impact on the respiratory and cardiovascular systems.The essential functionality of the significantly improved device will be to use it in mitigating the effects of the abnormal rate of cough and at the same time to reduce the adverse reactions caused by the toxic substances absorbed by the body, mainly in the circulatory system.A significantly improved device will be in the form of sachets of a powder of which the active ingredient will be composed of:— ductility of the upper respiratory tract, — bruises, — which affect the physico-chemical parameters of the bronchi tree, — reducing the risk factors arising from the crushing of blood vessels, with special regard to the depletion of blood lipids and homocysteine levels, — reducing systemic oxidative stress, — permitted by the current right to be used in foods for special medical purposes.Use of active substances (English)
 
Property / summary: Reference_reference_programme_aids:SA.42799 (2015/X), aid_de_de minimis:§ 42 of the Regulation of the Minister of Infrastructure and Development of 10 July 2015 on the granting of financial assistance by the Polish Agency for Enterprise Development in the framework of the OP Smart Growth 2014-2020.The project involves the development and testing of a significantly improved device for patients suffering from chronic cough and other undesirable effects resulting from smoking or the inhalation of air contaminated by cigarettes, either from the main stream (smoke to be expired by the smoker) or by smoke to smoke the cigarette.The product of the category of FSMP to be used under medical supervision has been designed for patients with a so-called ‘couchery’, a cough that appears after cigarettes or smoking in other tobacco products and can lead to the throat.Side effects of active and passive smoking include almost every body of the organism, but have a negative impact on the respiratory and cardiovascular systems.The essential functionality of the significantly improved device will be to use it in mitigating the effects of the abnormal rate of cough and at the same time to reduce the adverse reactions caused by the toxic substances absorbed by the body, mainly in the circulatory system.A significantly improved device will be in the form of sachets of a powder of which the active ingredient will be composed of:— ductility of the upper respiratory tract, — bruises, — which affect the physico-chemical parameters of the bronchi tree, — reducing the risk factors arising from the crushing of blood vessels, with special regard to the depletion of blood lipids and homocysteine levels, — reducing systemic oxidative stress, — permitted by the current right to be used in foods for special medical purposes.Use of active substances (English) / rank
Normal rank
 

Revision as of 11:07, 14 October 2020

Project in Poland financed by DG Regio
Language Label Description Also known as
English
The development of a significantly improved device, food for special medical purposes, for patients suffering from chronic cough and other undesirable effects resulting from smoking or inhalation of air contaminated by cigarettes.
Project in Poland financed by DG Regio

    Statements

    country
    Poland
    0 references
    EU contribution
    170,400.0 zloty
    0 references
    40,896.0 Euro
    exchange rate to Euro
    0.24 Euro
    point in time
    13 January 2020
    0 references
    budget
    213,000.0 zloty
    0 references
    51,120.0 Euro
    exchange rate to Euro
    0.24 Euro
    point in time
    13 January 2020
    0 references
    co-financing rate
    80.0 percent
    0 references
    start time
    1 February 2017
    0 references
    end time
    30 September 2017
    0 references
    beneficiary name (string)
    EUROPHARMA ALLIANCE SP. Z O.O.
    0 references
    beneficiary
    Q2511615
    0 references
    summary
    Numer_referencyjny_programu_pomocowego: SA.42799(2015/X), pomoc_de_minimis: §42 rozporządzenia Ministra Infrastruktury i Rozwoju z dnia 10 lipca 2015 r. w sprawie udzielania przez Polską Agencję Rozwoju Przedsiębiorczości pomocy finansowej w ramach Programu Operacyjnego Inteligentny Rozwój 2014–2020. Projekt zakłada opracowanie i przebadanie znacząco ulepszonego wyrobu dla pacjentów cierpiących na przewlekły kaszel i inne działania niepożądane wynikające z palenia tytoniu lub wdychania powietrza zanieczyszczonego papierosowym dymem zarówno ze strumienia głównego (dym wydychany przez palacza) jak i strumienia bocznego czyli dymu tlącego się papierosa. Produkt z kategorii żywności specjalnego przeznaczenia medycznego do zastosowania pod nadzorem lekarza, zaprojektowano z myślą o pacjentach cierpiących na tzw. kaszel palacza, czyli kaszel, który pojawia się po papierosach lub paleniu innych wyrobów tytoniowych i może prowadzić do podrażnienia gardła. Działania niepożądane palenia czynnego oraz biernego tytoniu obejmują niemal każdy organ organizmu, ale najbardziej wpływają negatywnie na układy oddechowy i krążenia. Podstawową funkcjonalnością znacząco ulepszonego wyrobu będzie zastosowanie go w łagodzeniu objawów przewlekłego kaszlu oraz jednoczesne zmniejszenie działań niepożądanych wywoływanych przez substancje toksyczne wchłonięte przez organizm, głównie w układzie krążenia. Znacząco ulepszony wyrób będzie miał postać saszetek z proszkiem, w skład którego wejdą składniki aktywne: - powlekające śluzówkę górnych dróg oddechowych, - wykrztuśne, - wpływające na parametry fizyko-chemiczne wydzieliny drzewa oskrzelowego, - zmniejszające czynniki ryzyka powstawania miażdżycy naczyń krwionośnych ze szczególnym uwzględnieniem oksydacji lipidów krwi oraz poziomu homocysteiny, - zmniejszające ogólnoustrojowy stres oksydacyjny, - dopuszczone wg obowiązującego prawa do stosowania w żywności specjalnego przeznaczenia medycznego. Zastosowanie substancji aktywnych spowodu (Polish)
    0 references

    Identifiers

    Polish Kohesio ID
    POIR.02.03.02-02-0006/17
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q81013&oldid=6331018"